Market Cap : 53.81 M | Enterprise Value : 51.94 M | PE Ratio : At Loss | PB Ratio : 17.00 |
---|
NAS:REFR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:REFR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Research Frontiers's Earnings per Share (Diluted) for the three months ended in Mar. 2022 was $-0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.07.
Research Frontiers's EPS (Basic) for the three months ended in Mar. 2022 was $-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.07.
Research Frontiers's EPS without NRI for the three months ended in Mar. 2022 was $-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.07.
During the past 3 years, the average EPS without NRIGrowth Rate was 15.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Research Frontiers's highest 3-Year average EPS without NRI Growth Rate was 23.90% per year. The lowest was -25.30% per year. And the median was 2.80% per year.
The historical data trend for Research Frontiers's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electronic Components subindustry, Research Frontiers's EPS (Diluted), along with its competitors' market caps and EPS (Diluted) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Hardware industry and Technology sector, Research Frontiers's EPS (Diluted) distribution charts can be found below:
* The bar in red indicates where Research Frontiers's EPS (Diluted) falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Research Frontiers's Diluted EPS for the fiscal year that ended in Dec. 2021 is calculated as
Diluted EPS (A: Dec. 2021 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (-1.846 | - | 0) | / | 31.647 | |
= | -0.06 |
Research Frontiers's Diluted EPS for the quarter that ended in Mar. 2022 is calculated as
Diluted EPS (Q: Mar. 2022 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (-0.628 | - | 0) | / | 31.650 | |
= | -0.02 |
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Research Frontiers's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Douglas Family Trust | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
James & Jean Douglas Irrevocable Descendants Trust | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
Douglas Kevin | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
Settle William Graham | director | 6003 COBRIDGE SQUARE RALEIGH NC 27609 |
Lapointe Michael R | officer: VP-Marketing | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAPOINTE MICHAEL R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Harary Joseph M | director, officer: President and CEO | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: HARARY JOSEPH M a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Van Voorhees Seth | officer: CFO & VP-Business Development | 12 HARVEY DRIVE SHORT HILLS NJ 07078 |
Daigle Darryl | director | 3213 WYTCHWOOD DRIVE MORGAN CITY LA 70380 |
Kaganowicz Alexander | director | 1217 CARLLS STRAIGHT PATH DIX HILLS NY 11746 |
Grimes Gregory George | director | 24 FIFTH AVENUE APT. 1530 NEW YORK NY 10011 |
Slovak Steven Michael | officer: Vice President-Technology | 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797 |
Saxe Robert L | director, officer: Chairman of the Board | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAXE ROBERT L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Keen Victor F | director | C/O RESEARCH FRONTIERS INC. 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797 |
Guthrie Marion Philip | director | THREE LINCOLN CENTRE 5430 LBJ FWY., SUITE 1480 DALLAS TX 75240 |
Derby Jack | director | 399 BOYLSTON STREET BOSTON MA 02117 |
Other Sources
By Seekingalpha 2021-11-09